Meal replacement therapy for obesity and diabetes remission: efficacy assessment and considerations of barriers and facilitators to adherence among US individuals with low economic resources

被引：0

作者：

Durbin, Claudia G. ^{[1
]}

Hutchison, Ainsley ^{[2
]}

Colecchi, Talia ^{[3
]}

Mulligan, Jennifer ^{[4
,5
]}

Bodepudi, Sreevidya ^{[4
,5
]}

Zanni, Markella V. ^{[5
,6
]}

Anekwe, Chika Vera ^{[4
,5
]}

机构：

[1] NYU Grossman Sch Med, New York, NY USA

[2] Boston Univ, Boston, MA USA

[3] Univ Massachusetts, Amherst, MA USA

[4] Massachusetts Gen Hosp, MGH Weight Ctr, Dept Med, Div Endocrinol,Metab Unit, 50 Staniford St,Suite 430, Boston, MA 02114 USA

[5] Harvard Med Sch, Boston, MA 02115 USA

[6] Massachusetts Gen Hosp, Dept Med, Div Endocrinol, Metab Unit, Boston, MA USA

来源：

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS | 2025年 / 26卷 / 01期

关键词：

Meal replacement; Weight loss; Obesity; Diabetes; Low income; LIFE-STYLE INTERVENTION; RANDOMIZED CONTROLLED-TRIAL; WEIGHT-LOSS MAINTENANCE; GLYCEMIC CONTROL; FOOD-INSECURITY; RISK-FACTORS; LOSS PROGRAM; DIET; PLAN; METAANALYSIS;

D O I：

10.1007/s11154-024-09925-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Individuals in the United States with lower economic resources face a disproportionate burden of obesity and co-morbid conditions. This review summarizes the efficacy of MR programs for the treatment of obesity and diabetes and alerts clinicians to potential barriers and facilitators to the uptake of such programs so they may tailor their prescriptive approach. Implementation of effective behavioral and lifestyle interventions for obesity and diabetes in low-income settings is fraught with barriers and under-studied. The dearth of data on the use of MR programs in populations with low economic resources highlights a key area for future investigation.

引用

页码：113 / 124

页数：12